长江健康
(002435)
| 流通市值：32.35亿 | | | 总市值：33.25亿 |
| 流通股本：12.03亿 | | | 总股本：12.36亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,532,143,721.26 | 1,748,568,988.92 | 873,535,602.23 | 3,469,557,831.87 |
| 营业收入 | 2,532,143,721.26 | 1,748,568,988.92 | 873,535,602.23 | 3,469,557,831.87 |
| 二、营业总成本 | 2,460,592,081.8 | 1,658,645,893.69 | 792,274,243.76 | 3,398,474,442.31 |
| 营业成本 | 1,675,282,267.05 | 1,121,959,199.23 | 520,811,894.8 | 2,309,985,707 |
| 税金及附加 | 23,127,504.91 | 16,054,657.74 | 8,631,251.96 | 28,836,286.06 |
| 销售费用 | 503,257,760.33 | 357,840,726.76 | 183,732,085.4 | 718,812,924.76 |
| 管理费用 | 143,389,459.94 | 93,111,960.46 | 47,873,149.04 | 222,865,300.25 |
| 研发费用 | 48,112,588.36 | 25,500,250.84 | 10,056,677.28 | 47,923,001.06 |
| 财务费用 | 67,422,501.21 | 44,179,098.66 | 21,169,185.28 | 70,051,223.18 |
| 其中:利息费用 | 67,654,184.74 | 43,804,224.16 | 22,213,852.63 | 73,926,945.14 |
| 其中:利息收入 | 2,111,317.08 | 1,423,913.79 | 1,200,548.4 | 2,926,693.93 |
| 加:公允价值变动收益 | 921,987.84 | 106,003.49 | 349,976.1 | 150,921.76 |
| 加:投资收益 | 601,290.76 | 421,182.24 | 481,657.61 | 76,041.62 |
| 资产处置收益 | -73,345.31 | 0 | 0 | 1,246,545.03 |
| 资产减值损失(新) | -31,522,248.25 | -25,234,903.02 | -14,698,344.92 | -67,913,420.69 |
| 信用减值损失(新) | -4,944,726.11 | -2,998,787.46 | -2,294,594 | 33,946,796.89 |
| 其他收益 | 45,343,447.7 | 22,923,340.83 | 5,753,740.57 | 46,962,681.24 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 81,878,046.09 | 85,139,931.31 | 70,853,793.83 | 85,552,955.41 |
| 加:营业外收入 | 2,852,507.37 | 1,859,734.13 | 320,139.62 | 5,728,163.99 |
| 减:营业外支出 | 14,895,888.43 | 7,509,442.7 | 1,229,427.8 | 24,904,130.88 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 69,834,665.03 | 79,490,222.74 | 69,944,505.65 | 66,376,988.52 |
| 减:所得税费用 | 21,702,200.75 | 15,419,943.31 | 10,891,698.44 | 25,043,790.32 |
| 六、净利润 | 48,132,464.28 | 64,070,279.43 | 59,052,807.21 | 41,333,198.2 |
| 持续经营净利润 | 48,132,464.28 | 64,070,279.43 | 59,052,807.21 | 41,333,198.2 |
| 归属于母公司股东的净利润 | 67,167,790.78 | 74,125,193.61 | 60,141,015.34 | 65,190,392.13 |
| 少数股东损益 | -19,035,326.5 | -10,054,914.18 | -1,088,208.13 | -23,857,193.93 |
| (一)基本每股收益 | 0.05 | 0.06 | 0.05 | 0.05 |
| (二)稀释每股收益 | 0.05 | 0.06 | 0.05 | 0.05 |
| 八、其他综合收益 | 627,666.24 | 740,417.08 | -487,682.97 | 2,021,534.55 |
| 归属于母公司股东的其他综合收益 | 627,666.24 | 740,417.08 | -487,682.97 | 2,021,534.55 |
| 九、综合收益总额 | 48,760,130.52 | 64,810,696.51 | 58,565,124.24 | 43,354,732.75 |
| 归属于母公司股东的综合收益总额 | 67,795,457.02 | 74,865,610.69 | 59,653,332.37 | 67,211,926.68 |
| 归属于少数股东的综合收益总额 | -19,035,326.5 | -10,054,914.18 | -1,088,208.13 | -23,857,193.93 |
| 公告日期 | 2023-10-26 | 2023-08-29 | 2023-04-28 | 2023-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |